Sehresh is a biotechnology leader focused on early drug and clinical development program management. As Director at Sangamo Therapeutics, she leads an innovative gene therapy program for neuropathic pain. She holds a PhD from Texas A&M University and a certificate in AI in Pharma and Biotech from MIT Sloan.
She is passionate about advancing human health, with a strong focus on longevity and womens health. Sehresh actively engages in discussions about aging therapeutics and the momentum building in the FemTech space, seeing it as a top priority to address the challenges and opportunities in these fields.
Unique fact: She is exploring the idea that GLP-1s may be the first geroprotectives, or longevity drugs, to emerge from the pharmaceutical industry.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.